Keun S. Lee

Translational Cancer Research Branch
Goyang, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 127 publications

Perceptions and Use of Complementary and Alternative Medicine among Patients with Cancer and Their Family Members (KCSG PC21-19).

Perceptions and Use of Complementary and Alternative Medicine among Patients with Cancer and Their Family Members (KCSG PC21-19).

Journal: Cancer research and treatment

Published: November 18, 2025

Development and pilot testing of a personalised decision aid for decision-making regarding fertility preservation in young female patients with cancer: a study protocol.

Development and pilot testing of a personalised decision aid for decision-making regarding fertility preservation in young female patients with cancer: a study protocol.

Journal: BMJ open

Published: August 13, 2025

ASO Author Reflections: Multimodal Sentinel Lymph Node Mapping in Breast Cancer: Efficacy and Clinical Implications After Neoadjuvant Chemotherapy.

ASO Author Reflections: Multimodal Sentinel Lymph Node Mapping in Breast Cancer: Efficacy and Clinical Implications After Neoadjuvant Chemotherapy.

Journal: Annals of surgical oncology

Published: July 07, 2025

Clinical Application of Multimodal Sentinel Lymph Node-Mapping Method for Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy: A Final Analysis.

Clinical Application of Multimodal Sentinel Lymph Node-Mapping Method for Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy: A Final Analysis.

Journal: Annals of surgical oncology

Published: May 06, 2025

Association of potential biomarkers with clinical outcomes in metastatic triple-negative breast cancer treated with pembrolizumab or chemotherapy.

Association of potential biomarkers with clinical outcomes in metastatic triple-negative breast cancer treated with pembrolizumab or chemotherapy.

Journal: NPJ breast cancer

Published: April 10, 2025

Palbociclib plus endocrine therapy versus capecitabine in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer (Young-PEARL): overall survival analysis of a randomised, open-label, phase 2 study.

Palbociclib plus endocrine therapy versus capecitabine in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer (Young-PEARL): overall survival analysis of a randomised, open-label, phase 2 study.

Journal: The Lancet. Oncology

Published: September 10, 2024

Randomized, phase II trial to evaluate the efficacy and safety of atezolizumab plus capecitabine adjuvant therapy compared to capecitabine monotherapy for triple receptor-negative breast cancer with residual invasive cancer after neoadjuvant chemotherapy (MIRINAE trial, KCSG-BR18-21).

Randomized, phase II trial to evaluate the efficacy and safety of atezolizumab plus capecitabine adjuvant therapy compared to capecitabine monotherapy for triple receptor-negative breast cancer with residual invasive cancer after neoadjuvant chemotherapy (MIRINAE trial, KCSG-BR18-21).

Journal: BMC cancer

Published: September 06, 2024

Standardization of the Denver Developmental Screening Test for children in Seoul: a validity study.

Standardization of the Denver Developmental Screening Test for children in Seoul: a validity study.

Journal: Ewha medical journal

Published: August 26, 2024

Neoadjuvant Chemotherapy with Concurrent Letrozole for Estrogen Receptor-Positive and HER2-Negative Breast Cancer: An Open-Label, Single-Center, Nonrandomized Phase II Study (NeoCHAI).

Neoadjuvant Chemotherapy with Concurrent Letrozole for Estrogen Receptor-Positive and HER2-Negative Breast Cancer: An Open-Label, Single-Center, Nonrandomized Phase II Study (NeoCHAI).

Journal: Cancers

Published: July 30, 2024

Impact of a 24-Week Mobile App-Based Human Coaching Program on Body Composition and Lipid Metabolism in Breast Cancer Survivors With Overweight or Obesity: Single-Arm Prospective Cohort Study.

Impact of a 24-Week Mobile App-Based Human Coaching Program on Body Composition and Lipid Metabolism in Breast Cancer Survivors With Overweight or Obesity: Single-Arm Prospective Cohort Study.

Journal: JMIR mHealth and uHealth

Published: July 28, 2024

Correction: ASO Author Reflections: Assessing the Efficacy of Multimodal Sentinel Lymph Node Mapping in Breast Cancer Patients After Neoadjuvant Chemotherapy.

Correction: ASO Author Reflections: Assessing the Efficacy of Multimodal Sentinel Lymph Node Mapping in Breast Cancer Patients After Neoadjuvant Chemotherapy.

Journal: Annals of surgical oncology

Published: July 23, 2024

ASO Author Reflections: Assessing the Efficacy of Multimodal Sentinel Lymph Node Mapping in Breast Cancer Patients After Neoadjuvant Chemotherapy.

ASO Author Reflections: Assessing the Efficacy of Multimodal Sentinel Lymph Node Mapping in Breast Cancer Patients After Neoadjuvant Chemotherapy.

Journal: Annals of surgical oncology

Published: April 16, 2024

Showing 1-12 of 127

Last Updated: 09/26/2026